{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T19:22:56Z","timestamp":1769800976285,"version":"3.49.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Nature Scientific Foundation of China","doi-asserted-by":"crossref","award":["31670937"],"award-info":[{"award-number":["31670937"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"DOI":"10.1007\/s00018-025-06033-9","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T23:13:22Z","timestamp":1769123602000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A decoy oligodeoxynucleotide favors the differentiation of CpG ODN-induced B cells into IL-10-producing Breg-like cells over plasma cells by restoring IRF4\/IRF8 imbalance"],"prefix":"10.1007","volume":"83","author":[{"given":"Feiyu","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengnan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengru","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongli","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9061-6914","authenticated-orcid":false,"given":"Liying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"key":"6033_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.611795","volume":"12","author":"D Catal\u00e1n","year":"2021","unstructured":"Catal\u00e1n D, Mansilla MA, Ferrier A, Soto L, Oleinika K, Aguill\u00f3n JC et al (2021) Immunosuppressive mechanisms of regulatory B cells. Front Immunol 12:611795","journal-title":"Front Immunol"},{"key":"6033_CR2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1146\/annurev.immunol.20.100301.064842","volume":"20","author":"AM Krieg","year":"2002","unstructured":"Krieg AM (2002) CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 20:709\u2013760","journal-title":"Annu Rev Immunol"},{"issue":"6","key":"6033_CR3","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/nrd2059","volume":"5","author":"AM Krieg","year":"2006","unstructured":"Krieg AM (2006) Therapeutic potential of Toll-like receptor 9 activation. Nat Rev Drug Discov 5(6):471\u2013484","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"6033_CR4","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41574-024-00990-0","volume":"20","author":"Z Ahmad","year":"2024","unstructured":"Ahmad Z, Kahloan W, Rosen ED (2024) Transcriptional control of metabolism by interferon regulatory factors. Nat Rev Endocrinol 20(10):573\u2013587","journal-title":"Nat Rev Endocrinol"},{"key":"6033_CR5","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1146\/annurev.immunol.26.021607.090400","volume":"26","author":"T Tamura","year":"2008","unstructured":"Tamura T, Yanai H, Savitsky D, Taniguchi T (2008) The IRF family transcription factors in immunity and oncogenesis. Annu Rev Immunol 26:535\u2013584","journal-title":"Annu Rev Immunol"},{"issue":"79","key":"6033_CR6","doi-asserted-by":"publisher","first-page":"eade7953","DOI":"10.1126\/sciimmunol.ade7953","volume":"8","author":"O Fornes","year":"2023","unstructured":"Fornes O, Jia A, Kuehn HS, Min Q, Pannicke U, Schleussner N et al (2023) A multimorphic mutation in IRF4 causes human autosomal dominant combined immunodeficiency. Sci Immunol 8(79):eade7953","journal-title":"Sci Immunol"},{"key":"6033_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1101\/sqb.2013.78.020305","volume":"78","author":"H Singh","year":"2013","unstructured":"Singh H, Glasmacher E, Chang AB, Vander Lugt B (2013) The molecular choreography of IRF4 and IRF8 with immune system partners. Cold Spring Harb Symp Quant Biol 78:101\u2013104","journal-title":"Cold Spring Harb Symp Quant Biol"},{"issue":"5299","key":"6033_CR8","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1126\/science.275.5299.540","volume":"275","author":"HW Mittr\u00fccker","year":"1997","unstructured":"Mittr\u00fccker HW, Matsuyama T, Grossman A, K\u00fcndig TM, Potter J, Shahinian A et al (1997) Requirement for the transcription factor LSIRF\/IRF4 for mature B and T lymphocyte function. Science 275(5299):540\u20133","journal-title":"Science"},{"issue":"9","key":"6033_CR9","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/nri1900","volume":"6","author":"K Honda","year":"2006","unstructured":"Honda K, Taniguchi T (2006) IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 6(9):644\u2013658","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"6033_CR10","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.immuni.2013.04.009","volume":"38","author":"K Ochiai","year":"2013","unstructured":"Ochiai K, Maienschein-Cline M, Simonetti G, Chen J, Rosenthal R, Brink R et al (2013) Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4. Immunity 38(5):918\u2013929","journal-title":"Immunity"},{"key":"6033_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/msb.2011.25","volume":"7","author":"R Sciammas","year":"2011","unstructured":"Sciammas R, Li Y, Warmflash A, Song Y, Dinner AR, Singh H (2011) An incoherent regulatory network architecture that orchestrates B cell diversification in response to antigen signaling. Mol Syst Biol 7:495","journal-title":"Mol Syst Biol"},{"key":"6033_CR12","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20221292","author":"R Thouenon","year":"2023","unstructured":"Thouenon R, Chentout L, Moreno-Corona N, Poggi L, Lombardi EP, Hoareau B et al (2023) A neomorphic mutation in the interferon activation domain of IRF4 causes a dominant primary immunodeficiency. J Exp Med. 220(6): e 20221292 https:\/\/doi.org\/10.1084\/jem.20221292","journal-title":"J Exp Med"},{"issue":"12","key":"6033_CR13","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1084\/jem.190.12.1837","volume":"190","author":"S Gupta","year":"1999","unstructured":"Gupta S, Jiang M, Anthony A, Pernis AB (1999) Lineage-specific modulation of Interleukin 4 signaling by interferon regulatory factor 4. J Exp Med 190(12):1837\u20131848","journal-title":"J Exp Med"},{"issue":"4","key":"6033_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/pnasnexus\/pgae152","volume":"3","author":"R Higuchi","year":"2024","unstructured":"Higuchi R, Tanaka K, Saito Y, Murakami D, Nakagawa T, Nutt SL et al (2024) Type I interferon promotes the fate of Toll-like receptor 9-stimulated follicular B cells to plasma cell differentiation. PNAS Nexus 3(4):pgae152","journal-title":"PNAS Nexus"},{"issue":"12","key":"6033_CR15","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/ni.3287","volume":"16","author":"H Xu","year":"2015","unstructured":"Xu H, Chaudhri VK, Wu Z, Biliouris K, Dienger-Stambaugh K, Rochman Y et al (2015) Regulation of bifurcating B cell trajectories by mutual antagonism between transcription factors IRF4 and IRF8. Nat Immunol 16(12):1274\u201381","journal-title":"Nat Immunol"},{"issue":"19","key":"6033_CR16","doi-asserted-by":"publisher","first-page":"9511","DOI":"10.1073\/pnas.1901258116","volume":"116","author":"H Wang","year":"2019","unstructured":"Wang H, Jain S, Li P, Lin JX, Oh J, Qi C et al (2019) Transcription factors IRF8 and PU.1 are required for follicular B cell development and BCL6-driven germinal center responses. Proc Natl Acad Sci U S A 116(19):9511\u201320","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"6033_CR17","doi-asserted-by":"publisher","first-page":"4028","DOI":"10.1182\/blood-2008-01-129049","volume":"112","author":"H Wang","year":"2008","unstructured":"Wang H, Lee CH, Qi C, Tailor P, Feng J, Abbasi S et al (2008) IRF8 regulates B-cell lineage specification, commitment, and differentiation. Blood 112(10):4028\u201338","journal-title":"Blood"},{"issue":"3","key":"6033_CR18","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.4049\/jimmunol.1001950","volume":"186","author":"J Feng","year":"2011","unstructured":"Feng J, Wang H, Shin DM, Masiuk M, Qi CF, Morse HC 3rd (2011) IFN regulatory factor 8 restricts the size of the marginal zone and follicular B cell pools. J Immunol 186(3):1458\u201366","journal-title":"J Immunol"},{"issue":"1","key":"6033_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1084\/jem.20051450","volume":"203","author":"CH Lee","year":"2006","unstructured":"Lee CH, Melchers M, Wang H, Torrey TA, Slota R, Qi CF et al (2006) Regulation of the germinal center gene program by interferon (IFN) regulatory factor 8\/IFN consensus sequence-binding protein. J Exp Med 203(1):63\u201372","journal-title":"J Exp Med"},{"issue":"2","key":"6033_CR20","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0092-8674(00)81348-3","volume":"87","author":"T Holtschke","year":"1996","unstructured":"Holtschke T, L\u00f6hler J, Kanno Y, Fehr T, Giese N, Rosenbauer F et al (1996) Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell 87(2):307\u201317","journal-title":"Cell"},{"issue":"19","key":"6033_CR21","doi-asserted-by":"publisher","first-page":"e2101031","DOI":"10.1002\/advs.202101031","volume":"8","author":"D Li","year":"2021","unstructured":"Li D, Zhang Y, Qiu Q, Wang J, Zhao X, Jiao B et al (2021) IRF8 impacts Self-Renewal of hematopoietic stem cells by regulating TLR9 signaling pathway of innate immune cells. Adv Sci (Weinh) 8(19):e2101031","journal-title":"Adv Sci (Weinh)"},{"key":"6033_CR22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2109548118","author":"JK Choi","year":"2021","unstructured":"Choi JK, Yu CR, Bing SJ, Jittayasothorn Y, Mattapallil MJ, Kang M et al (2021) IL-27-producing B-1a cells suppress neuroinflammation and CNS autoimmune diseases. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.2109548118","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"6033_CR23","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1080\/08916934.2018.1454913","volume":"51","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Jia X, Xia Y, Li H, Chen F, Zhu J et al (2018) Altered expression of transcription factors IRF4 and IRF8 in peripheral blood B cells is associated with clinical severity and circulating plasma cells frequency in patients with myasthenia gravis. Autoimmunity 51(3):126\u201334","journal-title":"Autoimmunity"},{"issue":"19","key":"6033_CR24","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1182\/blood-2017-05-782466","volume":"130","author":"JC Poe","year":"2017","unstructured":"Poe JC, Jia W, Su H, Anand S, Rose JJ, Tata PV et al (2017) An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD. Blood 130(19):2131\u201345","journal-title":"Blood"},{"key":"6033_CR25","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.coi.2019.09.004","volume":"61","author":"JL Barnas","year":"2019","unstructured":"Barnas JL, Looney RJ, Anolik JH (2019) B cell targeted therapies in autoimmune disease. Curr Opin Immunol 61:92\u201399","journal-title":"Curr Opin Immunol"},{"key":"6033_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.581119","volume":"11","author":"J Mastio","year":"2020","unstructured":"Mastio J, Saeed MB, Wurzer H, Krecke M, Westerberg LS, Thomas C (2020) Higher incidence of B cell malignancies in primary immunodeficiencies: a combination of intrinsic genomic instability and exocytosis defects at the immunological synapse. Front Immunol 11:581119","journal-title":"Front Immunol"},{"key":"6033_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1034667","volume":"13","author":"C Ma","year":"2022","unstructured":"Ma C, Liu H, Yang S, Li H, Liao X, Kang Y (2022) The emerging roles and therapeutic potential of B cells in sepsis. Front Pharmacol 13:1034667","journal-title":"Front Pharmacol"},{"key":"6033_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/7408967","volume":"2023","author":"X Dong","year":"2023","unstructured":"Dong X, Tu H, Qin S, Bai X, Yang F, Li Z (2023) Insights into the roles of B cells in patients with sepsis. J Immunol Res 2023:7408967","journal-title":"J Immunol Res"},{"issue":"7","key":"6033_CR29","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/s41423-024-01165-7","volume":"21","author":"C Tan","year":"2024","unstructured":"Tan C, Reilly B, Ma G, Murao A, Jha A, Aziz M et al (2024) Neutrophils disrupt B-1a cell homeostasis by targeting Siglec-G to exacerbate sepsis. Cell Mol Immunol 21(7):707\u201322","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"6033_CR30","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/s41467-023-44382-w","volume":"15","author":"SE McGettigan","year":"2024","unstructured":"McGettigan SE, Aira LE, Kumar G, Ballet R, Butcher EC, Baumgarth N et al (2024) Secreted IgM modulates IL-10 expression in B cells. Nat Commun 15(1):324","journal-title":"Nat Commun"},{"key":"6033_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1413177","volume":"15","author":"X Yang","year":"2024","unstructured":"Yang X, Huang J, Peng J, Wang P, Wong FS, Wang R et al (2024) Gut microbiota from B-cell-specific TLR9-deficient NOD mice promote IL-10(+) Breg cells and protect against T1D. Front Immunol 15:1413177","journal-title":"Front Immunol"},{"issue":"10","key":"6033_CR32","doi-asserted-by":"publisher","first-page":"4213","DOI":"10.1007\/s00253-021-11316-9","volume":"105","author":"W Lu","year":"2021","unstructured":"Lu W, Cui C, Wang Y, Sun X, Wang S, Yang M et al (2021) CpG ODN as an adjuvant arouses the vigor of B cells by relieving the negative regulation of surface TLR9 to enhance the antibody response to vaccine. Appl Microbiol Biotechnol 105(10):4213\u201324","journal-title":"Appl Microbiol Biotechnol"},{"key":"6033_CR33","doi-asserted-by":"publisher","first-page":"166","DOI":"10.2119\/molmed.2016.00243","volume":"23","author":"Y Xiao","year":"2017","unstructured":"Xiao Y, Lu W, Li X, Zhao P, Yao Y, Wang X et al (2017) An oligodeoxynucleotide with AAAG repeats significantly attenuates burn-induced systemic inflammatory responses via inhibiting interferon regulatory factor 5 pathway. Mol Med 23:166\u2013176","journal-title":"Mol Med"},{"key":"6033_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18051034","author":"S Gao","year":"2017","unstructured":"Gao S, Li X, Nie S, Yang L, Tu L, Dong B et al (2017) An AAAG-rich oligodeoxynucleotide rescues mice from bacterial septic peritonitis by interfering interferon regulatory factor 5. Int J Mol Sci. 18(5): 1034 https:\/\/doi.org\/10.3390\/ijms18051034","journal-title":"Int J Mol Sci"},{"issue":"3","key":"6033_CR35","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1182\/bloodadvances.2023010362","volume":"8","author":"SJ Bracken","year":"2024","unstructured":"Bracken SJ, Suthers AN, DiCioccio RA, Su H, Anand S, Poe JC et al (2024) Heightened TLR7 signaling primes BCR-activated B cells in chronic graft-versus-host disease for effector functions. Blood Adv 8(3):667\u201380","journal-title":"Blood Adv"},{"issue":"2","key":"6033_CR36","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.bbrc.2011.10.062","volume":"415","author":"M Fang","year":"2011","unstructured":"Fang M, Wan M, Guo S, Sun R, Yang M, Zhao T et al (2011) An oligodeoxynucleotide capable of lessening acute lung inflammatory injury in mice infected by influenza virus. Biochem Biophys Res Commun 415(2):342\u20137","journal-title":"Biochem Biophys Res Commun"},{"key":"6033_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21020552","author":"HJ An","year":"2020","unstructured":"An HJ, Kim JY, Gwon MG, Gu H, Kim HJ, Leem J et al (2020) Beneficial effects of SREBP decoy oligodeoxynucleotide in an animal model of hyperlipidemia. Int J Mol Sci. 21(2): 552 https:\/\/doi.org\/10.3390\/ijms21020552","journal-title":"Int J Mol Sci"},{"issue":"9","key":"6033_CR38","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1172\/JCI11459","volume":"106","author":"MJ Mann","year":"2000","unstructured":"Mann MJ, Dzau VJ (2000) Therapeutic applications of transcription factor decoy oligonucleotides. J Clin Invest 106(9):1071\u20131075","journal-title":"J Clin Invest"},{"key":"6033_CR39","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.phrs.2015.11.010","volume":"105","author":"D Bayik","year":"2016","unstructured":"Bayik D, Gursel I, Klinman DM (2016) Structure, mechanism and therapeutic utility of immunosuppressive oligonucleotides. Pharmacol Res 105:216\u2013225","journal-title":"Pharmacol Res"},{"key":"6033_CR40","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.molimm.2018.01.005","volume":"94","author":"P Zhang","year":"2018","unstructured":"Zhang P, Yang CL, Liu RT, Li H, Zhang M, Zhang N et al (2018) Toll-like receptor 9 antagonist suppresses humoral immunity in experimental autoimmune myasthenia gravis. Mol Immunol 94:200\u20138","journal-title":"Mol Immunol"},{"key":"6033_CR41","doi-asserted-by":"publisher","first-page":"217297","DOI":"10.1155\/2013\/217297","volume":"2013","author":"O Boehm","year":"2013","unstructured":"Boehm O, Markowski P, van der Giet M, Gielen V, Kokalova A, Brill C et al (2013) In vivo TLR9 Inhibition attenuates CpG-induced myocardial dysfunction. Mediators Inflamm 2013:217297","journal-title":"Mediators Inflamm"},{"issue":"10","key":"6033_CR42","doi-asserted-by":"publisher","first-page":"5590","DOI":"10.4049\/jimmunol.169.10.5590","volume":"169","author":"H Yamada","year":"2002","unstructured":"Yamada H, Gursel I, Takeshita F, Conover J, Ishii KJ, Gursel M et al (2002) Effect of suppressive DNA on CpG-induced immune activation. J Immunol 169(10):5590\u20134","journal-title":"J Immunol"},{"issue":"3","key":"6033_CR43","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.clim.2011.04.016","volume":"140","author":"C He","year":"2011","unstructured":"He C, Zhou L, Sun R, Zhao T, Zhang Y, Fu Y et al (2011) Effects of oligodeoxynucleotide with CCT repeats on chronic graft versus host disease induced experimental lupus nephritis in mice. Clin Immunol 140(3):300\u20136","journal-title":"Clin Immunol"},{"issue":"19","key":"6033_CR44","doi-asserted-by":"publisher","first-page":"11600","DOI":"10.1128\/JVI.01876-14","volume":"88","author":"CG Matar","year":"2014","unstructured":"Matar CG, Rangaswamy US, Wakeman BS, Iwakoshi N, Speck SH (2014) Murine gammaherpesvirus 68 reactivation from B cells requires IRF4 but not XBP-1. J Virol 88(19):11600\u201311610","journal-title":"J Virol"},{"issue":"1","key":"6033_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003858","volume":"10","author":"US Rangaswamy","year":"2014","unstructured":"Rangaswamy US, Speck SH (2014) Murine gammaherpesvirus M2 protein induction of IRF4 via the NFAT pathway leads to IL-10 expression in B cells. PLoS Pathog 10(1):e1003858","journal-title":"PLoS Pathog"},{"issue":"7","key":"6033_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05954-2","volume":"14","author":"Z Sun","year":"2023","unstructured":"Sun Z, Chen A, Fang H, Sun D, Huang M, Cheng E et al (2023) B cell-derived IL-10 promotes the resolution of lipopolysaccharide-induced acute lung injury. Cell Death Dis 14(7):418","journal-title":"Cell Death Dis"},{"issue":"8","key":"6033_CR47","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1084\/jem.20062567","volume":"204","author":"JR Groom","year":"2007","unstructured":"Groom JR, Fletcher CA, Walters SN, Grey ST, Watt SV, Sweet MJ et al (2007) BAFF and MyD88 signals promote a lupuslike disease independent of T cells. J Exp Med 204(8):1959\u201371","journal-title":"J Exp Med"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-025-06033-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-06033-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-06033-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T06:03:39Z","timestamp":1769753019000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-025-06033-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6033"],"URL":"https:\/\/doi.org\/10.1007\/s00018-025-06033-9","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]},"assertion":[{"value":"18 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The mouse experiments were approved by the ethics committee of the College of Basic Medical Sciences, Jilin University (2024\u2009\u2212\u2009295), and in accordance with the National Institute of Health Guide for the Care and Use of Laboratory Animals (NIH Publications No. 80\u2009\u2212\u200923) revised in 1996 and the guidelines of Jilin University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests associated with the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"76"}}